Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pets at Home Group Plc | 6P8 | Nov 26, 2024 | 3.30 | -0.96 |
Peugeot Invest | FFP | Nov 26, 2024 | 69.90 | -1.55 |
PEXA AB SER.B | FA0 | Nov 26, 2024 | 0.02 | 0.00 |
Pexip Holding | 4W9 | Nov 26, 2024 | 3.69 | 0.00 |
Peyto Exploration & Development Corp. | PXK | Nov 26, 2024 | 11.34 | -0.83 |
Pfeiffer Vacuum Technology AG | PFV | Nov 26, 2024 | 154.20 | +0.13 |
Pferdewetten.de AG | EMH | Nov 26, 2024 | 4.68 | -0.85 |
PFERDEWETTEN.DE NA NEUE | EMH0 | Nov 26, 2024 | 3.30 | -2.94 |
PFIZER INC.CDR REG.S | PFEB | Nov 26, 2024 | 8.55 | +8.23 |
Pfizer, Inc. | PFE | Nov 26, 2024 | 24.59 | -0.51 |
PGE Polska Grupa Energetyczna SA | 6PG | Nov 26, 2024 | 1.59 | +1.11 |
Pharmamar S.A. | PMRA | Nov 26, 2024 | 74.95 | +1.97 |
Pharmanutra S.p.A. | 761 | Nov 26, 2024 | 54.90 | +0.55 |
Pharmaron Beijing Co Ltd | 17Q1 | Nov 26, 2024 | 1.65 | +5.77 |
PHARMASGP HOLDING SE O.N. | PSG | Nov 26, 2024 | 24.20 | +5.22 |
Pharmaust Ltd. | ECQ | Nov 26, 2024 | 0.13 | 0.00 |
Pharming Group N.V. - ADS, each representing 10 ordinary sha | PHG | Nov 26, 2024 | 6.90 | -1.43 |
Pharming Group NV | PHGN | Nov 26, 2024 | 0.72 | +1.20 |
PHarol SGPS SA | PTCA | Nov 26, 2024 | 0.04 | +0.96 |
Pharos Energy Plc | OCS1 | Nov 26, 2024 | 0.25 | -5.97 |
Pharvaris N.V. - Ordinary Shares | 9EN | Nov 26, 2024 | 21.80 | +2.83 |
PHASE HOLO.IMAG.PHI SK-20 | L5W | Nov 26, 2024 | 0.15 | -9.03 |
PHAXIAM THERAPEUT. EO 1,- | 2E40 | Nov 26, 2024 | 1.46 | -3.70 |
PHC Holdings Corporation | 2GY | Nov 26, 2024 | 6.20 | -2.36 |
PhenixFIN | Q29 | Nov 26, 2024 | 43.80 | +1.39 |
Phenom Resources Corp | 1PY0 | Nov 26, 2024 | 0.26 | -6.47 |
Phibro Animal Health Corporation - Class A | PB8 | Nov 26, 2024 | 22.80 | +1.79 |
Phicomm AG | HBD1 | Nov 26, 2024 | 0.94 | 0.00 |
Philion Se Bearer NPV | PH6 | Nov 26, 2024 | 0.45 | +0.90 |
Philip Morris Cr A.S. | TBK | Nov 26, 2024 | 633.00 | +0.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.